143 related articles for article (PubMed ID: 9352120)
1. Ineffectiveness of the presence of H-ras/p53 combination of mutations in squamous cell carcinoma cells to induce a conversion of a nontumorigenic to a tumorigenic phenotype.
Lee H; Li D; Prior T; Casto BC; Weghorst CM; Shuler CF; Milo GE
Cell Biol Toxicol; 1997 Oct; 13(6):419-34. PubMed ID: 9352120
[TBL] [Abstract][Full Text] [Related]
2. Nontumorigenic squamous cell carcinoma line converted to tumorigenicity with methyl methanesulfonate without activation of HRAS or MYC.
Milo GE; Shuler C; Kurian P; French BT; Mannix DG; Noyes I; Hollering J; Sital N; Schuller D; Trewyn RW
Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1268-72. PubMed ID: 2406716
[TBL] [Abstract][Full Text] [Related]
3. Cloning and sequencing of CATR1.3, a human gene associated with tumorigenic conversion.
Li D; Noyes I; Shuler C; Milo GE
Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6409-13. PubMed ID: 7604004
[TBL] [Abstract][Full Text] [Related]
4. Noncorrelative c-myc and ras oncogene expression in squamous cell carcinoma cells with tumorigenic potential.
Shuler C; Kurian P; French BT; Noyes I; Sital N; Hollering J; Trewyn RW; Schuller D; Milo GE
Teratog Carcinog Mutagen; 1990; 10(1):53-65. PubMed ID: 1693449
[TBL] [Abstract][Full Text] [Related]
5. Possible role of activated ras genes in human esophageal carcinogenesis.
Galiana C; Fusco A; Martel N; Nishihira T; Hirohashi S; Yamasaki H
Int J Cancer; 1993 Jul; 54(6):978-82. PubMed ID: 8335405
[TBL] [Abstract][Full Text] [Related]
6. High mutation frequency at Ha-ras exons 1-4 in squamous cell carcinomas from PUVA-treated psoriasis patients.
Kreimer-Erlacher H; Seidl H; Bäck B; Kerl H; Wolf P
Photochem Photobiol; 2001 Aug; 74(2):323-30. PubMed ID: 11547572
[TBL] [Abstract][Full Text] [Related]
7. Murine squamous cell carcinoma cell lines produced by a complete carcinogenesis protocol with benzo[a]pyrene exhibit characteristic p53 mutations and the absence of H-ras and cyl 1/cyclin D1 abnormalities.
Ruggeri BA; Bauer B; Zhang SY; Klein-Szanto AJ
Carcinogenesis; 1994 Aug; 15(8):1613-9. PubMed ID: 8055640
[TBL] [Abstract][Full Text] [Related]
8. The p53 tumor-suppressor gene and ras oncogene mutations in oral squamous-cell carcinoma.
Sakai E; Rikimaru K; Ueda M; Matsumoto Y; Ishii N; Enomoto S; Yamamoto H; Tsuchida N
Int J Cancer; 1992 Dec; 52(6):867-72. PubMed ID: 1459726
[TBL] [Abstract][Full Text] [Related]
9. Malignant conversion of human cells by antisense cDNA to a putative tumor suppressor gene.
Li D; Yan H; Chen J; Casto BC; Theil KS; Milo GE
Carcinogenesis; 1996 Aug; 17(8):1751-5. PubMed ID: 8761437
[TBL] [Abstract][Full Text] [Related]
10. p53 and Kirsten-ras mutations in human mesothelioma cell lines.
Metcalf RA; Welsh JA; Bennett WP; Seddon MB; Lehman TA; Pelin K; Linnainmaa K; Tammilehto L; Mattson K; Gerwin BI
Cancer Res; 1992 May; 52(9):2610-5. PubMed ID: 1568228
[TBL] [Abstract][Full Text] [Related]
11. Characterization of novel cell lines established from three human oral squamous cell carcinomas.
Lee G; Kim YB; Kim JH; Kim MS; Shin KH; Won YS; Lee JI; Choung PH; Hyun BH; Min BM
Int J Oncol; 2002 Jun; 20(6):1151-9. PubMed ID: 12011992
[TBL] [Abstract][Full Text] [Related]
12. Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells.
Hietanen SH; Kurvinen K; Syrjänen K; Grénman S; Carey T; McClatchey K; Syrjänen S
Am J Obstet Gynecol; 1995 Nov; 173(5):1477-82. PubMed ID: 7503188
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the tumorigenicity of the X gene of hepatitis B virus in a nontransformed hepatocyte cell line and the effects of cotransfection with a murine p53 mutant equivalent to human codon 249.
Oguey D; Dumenco LL; Pierce RH; Fausto N
Hepatology; 1996 Nov; 24(5):1024-33. PubMed ID: 8903370
[TBL] [Abstract][Full Text] [Related]
14. p53 alterations in human squamous cell carcinomas and carcinoma cell lines.
Caamano J; Zhang SY; Rosvold EA; Bauer B; Klein-Szanto AJ
Am J Pathol; 1993 Apr; 142(4):1131-9. PubMed ID: 7682763
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization in vivo of mutant p53 molecules derived from squamous cell carcinomas of the head and neck.
Cardinali M; Kratochvil FJ; Ensley JF; Robbins KC; Yeudall WA
Mol Carcinog; 1997 Feb; 18(2):78-88. PubMed ID: 9049183
[TBL] [Abstract][Full Text] [Related]
16. Mutations associated with in vivo aflatoxin B1-induced carcinogenesis need not be present in the in vitro transformations by this toxin.
Stanley LA; Mandel HG; Riley J; Sinha S; Higginson FM; Judah DJ; Neal GE
Cancer Lett; 1999 Apr; 137(2):173-81. PubMed ID: 10374839
[TBL] [Abstract][Full Text] [Related]
17. Malignant transformation of rat embryo fibroblasts by cotransfection with eleven human mutant p53 cDNAs and activated H-ras gene.
Kikuchi-Yanoshita R; Tanaka K; Muraoka M; Konishi M; Kawashima I; Takamoto S; Hirai H; Miyaki M
Oncogene; 1995 Oct; 11(7):1339-45. PubMed ID: 7478555
[TBL] [Abstract][Full Text] [Related]
18. Activation of PTHrP gene expression in squamous carcinoma cell lines by mutant isoforms of the tumor suppressor p53.
Foley J; King CS; Jiménez JA; Wysolmerski JJ; Philbrick WM
Oncol Res; 2000; 12(2):71-81. PubMed ID: 11132926
[TBL] [Abstract][Full Text] [Related]
19. Molecular events including p53 and k-ras alterations in the in vitro progression of a human colorectal adenoma cell line to an adenocarcinoma.
Williams AC; Browne SJ; Yeudal WA; Paterson IC; Marshall CJ; Lane DP; Paraskeva C
Oncogene; 1993 Nov; 8(11):3063-72. PubMed ID: 8414507
[TBL] [Abstract][Full Text] [Related]
20. Conversion of premalignant human cells to tumorigenic cells by methylmethane sulfonate and methylnitronitrosoguanidine.
Milo GE; Shuler CF; Stoner G; Chen JC
Cell Biol Toxicol; 1992; 8(4):193-205. PubMed ID: 1337307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
